shadow follow leader
Pharma

Argenx reports Q3 sales bump and a new trial requirement

Argenx's third-quarter Vyvgart sales surge was overshadowed by high operating expenses and a confirmatory trial requirement from the FDA.
Donavyn Coffey Oct 23, 2026 11:42am
Texas Texas gavel gavel Texas law Texas court TX Attorney General Texas AG Ken Paxton

Gilead to pay $45M to resolve kickback allegations in Texas

Oct 23, 2026 10:57am
showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Lilly, Novo see script dip amid holiday

Oct 23, 2026 9:51am
Podcast
Fierces The Top Line logo appears over a pale yellow background patterned with diagonal yellow capsules

GSK's twin FDA wins, Roche's $15B deal and point-of-care ads

Oct 23, 2026 9:28am
Asia

COINS Act, Hengrui, Samsung Biologics—Fierce Pharma Asia

Oct 23, 2026 8:42am
Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together
Favicon Fierce Biotech

Treasury COINS rules add biotech, spares China licensing deals

Oct 22, 2026 11:36pm
More News

Real Chemistry champions health dignity initiative

Oct 22, 2026 8:18pm

Vabysmo shows signs of recovery as Roche gears up for busy 2027

Oct 22, 2026 11:20am

AZ lands 5th Ultomiris indication in kidney disease IgAN

Oct 22, 2026 11:15am

Esteve pledges $80M to overhaul its CDMO operations in China

Oct 22, 2026 10:52am